THC BIOMED INTL LTD ORD - THCBF STOCK NEWS

THC BioMed Intl (CSE:THC, OTCQB:THCBF) has commenced sales and export of its patented Clone Shipper containers to Asia, aimed at safe transport of cannabis plants. The container features a durable design with an opaque lid and an LED light for nurturing plants during shipping. THC BioMed is optimistic about entering the growing Asian medical cannabis market, which it anticipates will become the largest globally. The company, known for its organic and sustainable cultivation methods, has been licensed since 2016 and currently trades at $0.075.

THC BioMed Intl Ltd. has launched its THC KISS Cannabis Biscuits in Ontario, now available directly for consumers on the Ontario Cannabis Store, marking a significant step for the company. Priced at $2.95 for a pack containing 10 mg of THC, these biscuits are noted as the lowest-priced edibles in Ontario. The launch adds to the company's growing product line, with a total of 6 products listed on the Ontario Cannabis Store.

Additionally, THC BioMed plans to introduce a new brand named High Expectations, featuring high THC potency strains.

THC BioMed Intl Ltd. has received a licence from an overseas government to cultivate cannabis for medical and scientific purposes. This development comes as the company engages in advanced discussions with the host government to conduct scientific research, particularly focusing on the potential of cannabinoids like CBD to inhibit SARS-CoV-2 infection. While THC BioMed aims to lead in this research area, it emphasizes that no claims about curing COVID-19 have been made. The company has a history dating back to 2013 and has been a Licensed Producer since 2016.

THC BioMed Intl Ltd (CSE: THC; OTC: THCBF) announced its Q1 financial results ending October 31, 2021. The company reported a significant 83% revenue increase year-over-year, totaling $1,136,796. It achieved a gross margin of $711,761 and a net income of $25,006. Notably, edibles accounted for 21.3% of total sales. The company received a Notice of Allowance for a patent regarding its innovative Clone Shipper unit. Additionally, THC BioMed leased a new unit in Kelowna for administrative purposes.

THC BioMed Intl Ltd. announces that it will release its Q1 2021 financial statements for the period ending October 31, 2021, after market hours on November 30, 2021. As one of Canada’s oldest licensed cannabis companies, THC BioMed has been producing medical and recreational cannabis since 2013 and is focusing on leading the beverage and edible segments. The company aims to leverage its research capabilities in a rapidly growing industry.

THC BioMed Intl Ltd. announced the launch of three new products in Ontario: Dragon's Lettuce dried cannabis and THC Kiss Cannabis Biscuits in Cocoa and Cinnamon flavors. Dragon's Lettuce is a potent sativa strain with a minimum THC potency of 20%. The THC Kiss Biscuits are infused with 10 mg of THC KISS extract, a proprietary cannabis extract. The company aims to lead in the cannabis beverage and edible market, supported by its fully integrated facility in British Columbia. THC BioMed has been licensed since 2013 and continues to focus on product development and scientific research.

THC BioMed Intl Ltd. has announced it received orders from 30 dispensaries in Manitoba. The company has started shipping THC KISS cannabis edibles and dried cannabis to these dispensaries. The edible products contain 10 mg of THC KISS extract, a proprietary full-spectrum cannabis extract. THC BioMed is a licensed producer of cannabis products in Canada, focusing on edibles and beverages. All products are manufactured at their facility in British Columbia, and updates regarding dispensaries will be available on their website.

THC BioMed Intl Ltd. announced receiving a Notice of Allowance from the Canadian Patent and Trademark Office for its patent application concerning a Contrast Illuminated Tamper Resistant Plant Shipping Container. This Notice indicates the application is being approved but does not confer patent rights yet. The development represents a significant step in protecting the company's innovations in cannabis shipping solutions, potentially enhancing operational security and efficiency.

THC BioMed Intl Ltd. announced the shipment of its THC KISS Mango Beverage Shot to BC Cannabis Stores, marking a significant product launch for the company.

The beverage shots contain 10 mg of THC KISS extract, a proprietary, fast-acting full-spectrum cannabis extract developed by THC BioMed. THC KISS shots are available in Mango and Guava flavors. Established in 2013, THC BioMed is one of Canada's oldest active licensed cannabis companies, operating under the Cannabis Act.